0001209191-22-043994.txt : 20220802 0001209191-22-043994.hdr.sgml : 20220802 20220802191641 ACCESSION NUMBER: 0001209191-22-043994 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220802 FILED AS OF DATE: 20220802 DATE AS OF CHANGE: 20220802 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Blunt Roshawn A. CENTRAL INDEX KEY: 0001787773 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40315 FILM NUMBER: 221130502 MAIL ADDRESS: STREET 1: 11682 EL CAMINO REAL STE 300 CITY: SAN DIEGO STATE: CA ZIP: 92130 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Reneo Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001637715 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 472309515 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 18575 JAMBOREE ROAD STREET 2: SUITE 275-S CITY: IRVINE STATE: CA ZIP: 92612 BUSINESS PHONE: (858) 283-0280 MAIL ADDRESS: STREET 1: 18575 JAMBOREE ROAD STREET 2: SUITE 275-S CITY: IRVINE STATE: CA ZIP: 92612 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2022-08-02 0 0001637715 Reneo Pharmaceuticals, Inc. RPHM 0001787773 Blunt Roshawn A. C/O RENEO PHARMACEUTICALS, INC. 18575 JAMBOREE ROAD, SUITE 275-S IRVINE CA 92612 1 0 0 0 Stock Option (right to buy) 2.80 2022-08-02 4 A 0 35000 0.00 A 2032-08-01 Common Stock 35000 35000 D The shares subject to the stock option vest and become exercisable in equal monthly installments over a three-year period. /s/ Jennifer Lam, Attorney-in-Fact 2022-08-02